DR. JOYCE STEINBERG, MD
Osteopathic Medicine at Astellas Way, Northbrook, IL
License number
Illinois 036-069-559
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1 Astellas Way, Northbrook, IL 60062
Phone
(224) 205-8763
Personal information
See more information about JOYCE STEINBERG at radaris.comName
Address
Phone
1430 Voltz Rd, Northbrook, IL 60062
1847 Tanglewood Dr, Glenview, IL 60025
1430 Voltz Rd, Northbrook, IL 60062
5733 Sheridan Rd, Chicago, IL 60660
9409 Lorel Ave, Skokie, IL 60077
Organization information
See more information about JOYCE STEINBERG at bizstanding.comJoyce Steinberg MD
1430 Voltz Rd, Northbrook, IL 60062
Industry:
Internist
Joyce Leta Steinberg
Professional information
Dr. Joyce L Steinberg, Northbrook IL - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1 Astellas Way, Northbrook 60062
Certifications:
Internal Medicine, 1986, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1983
University Of Illinois
Princess Margaret Hosp
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1983
University Of Illinois
Princess Margaret Hosp
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
US Patent:
2009020, Aug 13, 2009
Filed:
Feb 5, 2009
Appl. No.:
12/365966
Inventors:
Joyce L. Steinberg - Northbrook IL, US
Neeraj Gupta - Waukegan IL, US
Rajendra S. Pradhan - Buffalo Grove IL, US
Sari H. Enschede - River Forest IL, US
Rod A. Humerickhouse - Highland Park IL, US
Neeraj Gupta - Waukegan IL, US
Rajendra S. Pradhan - Buffalo Grove IL, US
Sari H. Enschede - River Forest IL, US
Rod A. Humerickhouse - Highland Park IL, US
Assignee:
ABBOTT LABORATORIES - Abbott Park IL
International Classification:
A61K 31/416, A61K 31/506, A61P 35/00, A61K 31/517, A61K 31/44, A61K 47/08, A61K 47/14
US Classification:
51425218, 51425219, 51426622, 51426624, 514350, 514406, 514772, 514785
Abstract:
A pharmaceutical dosage form comprises a solid dispersion product of at least one tyrosine kinase inhibitor, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer.